Gabriele Arcari

Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical Isolates

Alessandra Carattoli, Gabriele Arcari, Giulia Bibbolino et al. · Antimicrobial Agents and Chemotherapy · 2021 · 91 citations · Full text

Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital

Gabriele Arcari, Giammarco Raponi, Federica Sacco et al. · International Journal of Antimicrobial Agents · 2020 · 59 citations · Full text

Klebsiella Pneumoniae, Healthcare-associated Infection, Italian Hospital +11

Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 <i>Klebsiella pneumoniae</i>–Producing KPC-31, a D179Y Variant of KPC-3

Giusy Tiseo, Marco Falcone, Alessandro Leonildi et al. · Open Forum Infectious Diseases · 2021 · 55 citations · Full text

Spread of hypervirulent multidrug-resistant ST147 <i>Klebsiella pneumoniae</i> in patients with severe COVID-19: an observational study from Italy, 2020–21

Marco Falcone, Giusy Tiseo, Gabriele Arcari et al. · Journal of Antimicrobial Chemotherapy · 2021 · 45 citations · Full text

Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared

Francesco Cogliati Dezza, Gabriele Arcari, Federica Alessi et al. · Antibiotics · 2022 · 33 citations · Full text